135 related articles for article (PubMed ID: 11248363)
21. In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication.
Kern ER; Kushner NL; Hartline CB; Williams-Aziz SL; Harden EA; Zhou S; Zemlicka J; Prichard MN
Antimicrob Agents Chemother; 2005 Mar; 49(3):1039-45. PubMed ID: 15728900
[TBL] [Abstract][Full Text] [Related]
22. The immunosuppressive agent mycophenolate mofetil markedly potentiates the activity of lobucavir [1R(1alpha,2beta,3alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine against different herpes viruses.
Neyts J; De Clercq E
Transplantation; 1999 Mar; 67(5):760-4. PubMed ID: 10096537
[TBL] [Abstract][Full Text] [Related]
23. Acyclovir - a review of the preclinical and early clinical data of a new antiherpes drug.
Brigden D; Fiddian P; Rosling AE; Ravenscroft T
Antiviral Res; 1981 Nov; 1(4):203-12. PubMed ID: 6280605
[TBL] [Abstract][Full Text] [Related]
24. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro.
Zakirova NF; Shipitsyn AV; Jasko MV; Prokofjeva MM; Andronova VL; Galegov GA; Prassolov VS; Kochetkov SN
Bioorg Med Chem; 2012 Oct; 20(19):5802-9. PubMed ID: 22954898
[TBL] [Abstract][Full Text] [Related]
25. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
26. Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy.
Hasegawa Y; Nishiyama Y; Imaizumi K; Ono N; Kinoshita T; Hatano S; Saito H; Shimokata K
Cancer Gene Ther; 2000 Apr; 7(4):557-62. PubMed ID: 10811473
[TBL] [Abstract][Full Text] [Related]
27. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
[TBL] [Abstract][Full Text] [Related]
28. Update on herpesvirus infections.
Griffiths P
J R Coll Physicians Lond; 1998; 32(3):199-202. PubMed ID: 9670143
[No Abstract] [Full Text] [Related]
29. Tricyclic nucleoside analogues as antiherpes agents.
Golankiewicz B; Ostrowski T
Antiviral Res; 2006 Sep; 71(2-3):134-40. PubMed ID: 16780965
[TBL] [Abstract][Full Text] [Related]
30. Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus -1: an in vitro study on virally infected Vero and MRC-5 cell lines.
Hafidh RR; Abdulamir AS; Abu Bakar F; Sekawi Z; Jahansheri F; Jalilian FA
BMC Complement Altern Med; 2015 Jun; 15():179. PubMed ID: 26062546
[TBL] [Abstract][Full Text] [Related]
31. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
[TBL] [Abstract][Full Text] [Related]
32. Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1.
Cheng YC; Huang ES; Lin JC; Mar EC; Pagano JS; Dutschman GE; Grill SP
Proc Natl Acad Sci U S A; 1983 May; 80(9):2767-70. PubMed ID: 6302704
[TBL] [Abstract][Full Text] [Related]
33. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
Wagstaff AJ; Faulds D; Goa KL
Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
[TBL] [Abstract][Full Text] [Related]
34. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
[TBL] [Abstract][Full Text] [Related]
35. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.
Field AK; Davies ME; DeWitt C; Perry HC; Liou R; Germershausen J; Karkas JD; Ashton WT; Johnston DB; Tolman RL
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4139-43. PubMed ID: 6306664
[TBL] [Abstract][Full Text] [Related]
36. Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents.
De Clercq E; Andrei G; Snoeck R; De Bolle L; Naesens L; Degrève B; Balzarini J; Zhang Y; Schols D; Leyssen P; Ying C; Neyts J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):271-85. PubMed ID: 11563039
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of orally administered Lobelia chinensis extracts on herpes simplex virus type 1 infection in BALB/c mice.
Kuo YC; Lee YC; Leu YL; Tsai WJ; Chang SC
Antiviral Res; 2008 Nov; 80(2):206-12. PubMed ID: 18621082
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of SQ 34,514: pharmacokinetics and efficacy in experimental herpesvirus infections in mice.
Braitman A; Swerdel MR; Olsen SJ; Tuomari AV; Lynch JS; Blue B; Michalik T; Field AK; Bonner DP; Clark JM
Antimicrob Agents Chemother; 1991 Jul; 35(7):1464-8. PubMed ID: 1656863
[TBL] [Abstract][Full Text] [Related]
39. Antiviral drugs for varicella-zoster virus and herpes simplex virus infections.
Med Lett Drugs Ther; 2018 Sep; 60(1556):153-157. PubMed ID: 30383727
[No Abstract] [Full Text] [Related]
40. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
